A Synergistic Interaction Between Lapatinib and Chemotherapy Agents in a Panel of Cell Lines Is Due to the Inhibition of the Efflux Pump BCRP

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search